SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as the cannabis sector rallies on reports of potential federal rescheduling, with buzz building around a possible executive order from President Trump. Community members are weighing the potential implications for tax relief, banking access, and institutional investment, while also debating optimal strategies given the stock's history of volatility. Bullish sentiment is strong, tempered by caution around past disappointments.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to speculation of an imminent short squeeze, fueled by its low float and recent AI and blockchain deal. Community chatter suggests a potential for significant upward movement, with some comparing it to other recent low-float runners. Traders are closely watching key breakout levels, anticipating a rapid price surge if volume increases.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

Ghost is trending as the community anticipates the launch of GhostPay. Social media buzz compares Ghost to other cryptocurrencies and highlights its potential for significant gains. Community members are actively encouraging others to join and are sharing contract addresses.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to its AI and Autonomy Day, where the company showcased its new in-house AI chip and self-driving capabilities, sparking discussions about its competitive positioning against Tesla. The community is actively debating the potential for a short squeeze and the implications of Rivian's technology roadmap, with some analysts raising their price targets on the stock.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token is trending as community members rally behind its potential as the next big Ethereum-based meme coin, citing a prophecy and strong community support. The launch of new perpetual markets and consistent buying during dips have further fueled confidence. Bullish sentiment suggests a belief in significant growth and a breakout moment for YEE within the broader ETH ecosystem.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

Mosaic Company is trending as investors weigh the impact of potential potash production cuts by Belarusian producers, which could support global pricing and benefit fertilizer companies; however, some analysts remain cautious about the stock's recent performance and potential headwinds from tariffs. Community discussions also highlight the stock's valuation and potential for a turnaround, with some pointing to the company's long-term potential in the agricultural sector amid concerns about food security.

Loopring is a Decentralized Exchange (DEX) built on an Ethereum Layer-2 (L2) solution called zkRollup. It has both Automated Market Maker (AMM)-based and orderbook-based exchanges.   zkRollup is an Ethereum L2 scaling solution that migrates computations off the blockchain. Loopring protocol only uses the underlying Ethereum blockchain as a data layer and a verification layer. As a result, Loopring's throughput is as high as 2,025 trades per second compared to Ethereum’s current throughput of 15 transactions per second. The result is that the cost per trade settlement is as small as $0.00015.  Loopring's performance is sufficient for professional traders and market makers to deploy algorithmic strategies and other automated trading bots. This was not previously possible on any DEX as it was prohibitively slow and expensive. By building on top of Loopring 3.0, orderbook-based DEXs can be commercially viable for the first time. Loopring expects non-custodial exchanges can begin to outcompete and displace many centralized counterparts.

Loopring

Loopring is trending as the crypto market shows signs of a potential rally, with community members discussing AI-related catalysts like project "PROMPT" and its connection to Nvidia. Bullish sentiment is building, with some traders eyeing a potential short squeeze and others pointing to inverse head and shoulders patterns as indicators of an upcoming price surge. Community members are actively monitoring Loopring's chart, anticipating a breakout toward higher price targets.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending as the stock price is surging in advance of upcoming earnings, with increased community discussion around the company's critical role in the AI semiconductor supply chain.  Bulls are highlighting ASML's monopoly in EUV lithography and anticipating significant long-term growth, while some bears express concerns about valuation and potential export restrictions.  The stock is viewed by many as a key beneficiary of the AI infrastructure buildout, with the overall sentiment leaning bullish.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as community members highlight its potential as a high-speed, compliance-focused Layer 1 solution for institutional finance. Discussions emphasize Keeta's recent integration with Bridge, enabling seamless fiat on/off-ramps, and its impressive transaction throughput. Community members view Keeta as a foundational layer for global financial plumbing, positioned to complement established networks.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending due to community discussion around the potential of its drug, Sonelokimab (SLK), for treating hidradenitis suppurativa (HS) and its upcoming FDA meeting.  Traders are comparing SLK's efficacy data favorably against existing treatments, particularly regarding long-term results and safety profiles. The community is also speculating about a potential buyout, given the drug's market potential and previous acquisition interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TFG Asset Management GP Ltd Increases Position in Axsome Therapeutics, Inc. $AXSM

TFG Asset Management GP Ltd boosted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 22.9% during the second quarter, according to its most recent disclosure with...

Axsome Therapeutics, Inc. $AXSM Position Lowered by Eventide Asset Management LLC

Eventide Asset Management LLC trimmed its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 2.6% in the second quarter, according to its most recent disclosure with the SEC. The...

Bellevue Group AG Decreases Stake in Axsome Therapeutics, Inc. $AXSM

Bellevue Group AG cut its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 41.7% in the second quarter, according to the company in its most recent disclosure with the SEC...

9,555 Shares in Axsome Therapeutics, Inc. $AXSM Purchased by WINTON GROUP Ltd

WINTON GROUP Ltd bought a new stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the...

Hood River Capital Management LLC Acquires Shares of 371,104 Axsome Therapeutics, Inc. $AXSM

Hood River Capital Management LLC acquired a new position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC...

Kennedy Capital Management LLC Boosts Holdings in Axsome Therapeutics, Inc. $AXSM

Kennedy Capital Management LLC boosted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 380.2% in the second quarter, according to the company in its most recent 13F...

Quantbot Technologies LP Grows Position in Axsome Therapeutics, Inc. $AXSM

Quantbot Technologies LP lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 6,943.2% in the second quarter, according to its most recent 13F filing with the...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) have earned an average rating of "Moderate Buy" from the eighteen brokerages that are currently covering the firm, MarketBeat...

Axsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 20,163 Shares

Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) CEO Herriot Tabuteau sold 20,163 shares of the company's stock in a transaction on Wednesday, December 3rd. The shares were sold at an...

Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $7,121,346.68 in Stock

Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) CEO Herriot Tabuteau sold 49,252 shares of Axsome Therapeutics stock in a transaction dated Tuesday, December 2nd. The shares were sold at an...

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Current Price	$148.17
Prev Close	$148.75
Open	$148.67
Dividend Yield	0.00%
50-Day Moving Average	$137.18
Beta	0.78
Avg. Volume	599,854.42
PE Ratio	-31.70

52-Week High	$152.94
52-Week Low	$75.56
Market Capitalization	$7.47B
EPS (Annual)	-$5.99
Price to Book	101.10
Revenue Per Employee	$564,704.25
Enterprise Value/EBITDA	N/A

AXSM
Axsome Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AXSM News

AXSMAxsome Therapeutics Inc